(RTLX, IBIO, GVP) CRWENewswire Stocks In Action
For the fourth quarter of 2011, Retalix Ltd - RTLX - posted total revenues of $62.5 million, a 16.2% increase year over year. GSE Systems Inc - GVP - announced new contracts valued at approximately $8.0 million involving nuclear, fossil, and process simulation, tutorials, and consulting services. Each of these projects was awarded during the first quarter of 2012. iBio Inc - IBIO - reported issuance of a US patent covering the use of iBio’s proprietary fusion-protein technology in combination with influenza virus antigens for vaccine product applications.

*********************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).

ユーザー：karmastock
再生時間：00:01:10
投稿日時：12/03/01 3:54
カテゴリ：ビジネス全般 
タグ： RTLX  GVP  IBIO  Amex:GVP  Amex:IBIO  Nasdaq:RTLX 

[ 前ページへ戻る ]